Vistagen Therapeutics - VTGN Sotuvning sof marjinal rentabelligi

VistaGen Therapeutics Inc (VTGN) tovar belgisi

Vistagen Therapeutics (VTGN) nevrologiya uchun biologik preparatlarni ishlab chiqadi va xomashyo ta'minotini forvard shartnomalari orqali mustahkamlaydi. Xavotirga qarshi vositalarning robotlashtirilgan sintezi ekspert psixiatrik nazorati bilan to'ldiriladi. Ushbu grafikdagi kompaniyaning sof marjasi samaradorlik dinamikasini namoyish etadi, bunda -2474.50 ushbu ko'rsatkichning joriy holatini tavsiflaydi. Hozirda daromad mavjud bo'lmasa-da, burun sprey-lari uchun kelgusidagi patentlar sezilarli narx belgilash imkoniyatini ta'minlaydi.

Vistagen (VTGN) - Sof marja 04.07.2022dan 20.11.2026gacha

VTGN (Vistagen): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:VistaGen Therapeutics, Inc. - VTGN
vistagen.com yetakchi tovari

Vistagen Therapeutics hid bilish retseptorlarini nishonga oluvchi xavotir buzilishlari uchun innovatsion burun terapiyalarini ishlab chiqadi. Savdo va ishlab chiqarish faoliyati uchun sof marja tendentsiyasi ushbu ishlanmalarning operatsion xarajatlarga nisbatan samaradorligini aks ettiradi. Ushbu ko'rsatkich sof foydaning daromadga nisbati sifatida hisoblanadi va barcha chegirimlardan keyin qolgan foyda qismini o'lchaydi. Ushbu ko'rsatkichning o'sishi biznes modelining kengaytirish imkoniyatlarini tasdiqlaydi. Investorlar haddan tashqari qizigan aktivni sotib olishdan qochish uchun yo'qotishlar assimetriyasini hisobga olishlari kerak.

Raqobatdosh kompaniyalar tahlili

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi OVID (ovidrx.com)|Sof marja Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Sof marja|Alterity Therapeutics Ltd. - Sof foyda bo'yicha sotuv rentabelligi|CLNN - Sof foyda bo'yicha sotuv rentabelligi|PEPG - Sof marja|Kompaniya sotuv marjasi jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Sof marja|ANVS (Annovis Bio, Inc.) - Sof marja|Sof marja gracetx.com|Sotuvning sof marjinal rentabelligi Firefly Neuroscience, Inc.|Sof marja ANEW Medical (KLTO)|NRSN - Sof marja|Sotuvning sof marjinal rentabelligi RVPH (Reviva Pharmaceuticals Holdings Inc.)|Kompaniyaning sof rentabelligi MTVA (metaviatx.com)|NeurAxis Inc. - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi heliusmedical.com HSDT|PASG: Sotuvning sof marjinal rentabelligi|Neuphoria - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NERV|ATHA: Sof foyda normasi|Sof marja Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi CYCN (cyclerion.com)|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel